MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Unique advanced herbal product indicated for the treatment of ischaemic heart condition, diabetes, diabetic lesions and circulatory diseases as well.

Our client has developed and tested a unique advanced herbal formulation capable of reverting ischaemic heart conditions and complications associated with diabetic foot; as well as re-establishing blood flow in circulatory pathologies.

Full description

Our clients has developed a unique advanced herbal formulation with the ability of reverting ischaemic heart conditions and diabetic foot; as well as re-establish blood flow in circulatory pathologies. Ischaemia and diabetes together are responsible for over 20% (depending on source) of the world's mortality. This product, already the subject of scientific papers is the only product of its kind developed to address these conditions.

Exhibiting no side effects and already providing promising results in the patient studies carried out, our client's product cleanses arteries in patients suffering from heart conditions such as ischaemia and atherosclerosis.

This advanced herbal formulation is already patented in various countries (USA, Russia and Mexico) and is elaborated, according to GMP, by a certified US laboratory.

 

Development status

Phase II

Type of business relationship sought

Our clients are seeking global partner(s) to take the development and commercialization of this advanced circulatory product further. An attractive partner is a company that has the financial muscle as well as sales and marketing capabilities to ensure this product reaches the aforementioned specific therapeutic niche(s) in the international market.

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us